BOULDER, Colo. (AP) — BOULDER, Colo. (AP) — Fresh Tracks Therapeutics, Inc. (FRTX) on Friday reported a loss of $2.3 million in its second quarter.
The Boulder, Colorado-based company said it had a loss of 39 cents per share.
The drug developer posted revenue of $53,000 in the period.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on FRTX at https://www.zacks.com/ap/FRTX
Copyright © 2023 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
